Rosenbaum Jay D. Novartis Ag Transaction History

Rosenbaum Jay D.

$3.04 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $403,681 - $444,237	-4,375 Reduced 51.14%	4,180 $422,000
Q3 2023 Oct 23, 2023	BUY	$94.73 - $105.13 $28,419 - $31,539	300 Added 3.63%	8,555 $871,000
Q2 2023 Jul 27, 2023	BUY	$92.52 - $104.91 $28,311 - $32,102	306 Added 3.85%	8,255 $833,000
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $76,748 - $89,004	959 Added 13.72%	7,949 $731,000
Q4 2022 Feb 08, 2023	SELL	$75.55 - $92.52 $71,319 - $87,338	-944 Reduced 11.9%	6,990 $634,000
Q3 2022 Nov 09, 2022	BUY	$74.61 - $87.26 $4,551 - $5,322	61 Added 0.77%	7,934 $603,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $70,616 - $82,218	-877 Reduced 10.02%	7,873 $666,000
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $29,640 - $33,529	370 Added 4.42%	8,750 $768,000
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $28,452 - $31,462	-357 Reduced 4.09%	8,380 $733,000
Q3 2021 Oct 26, 2021	BUY	$81.78 - $95.14 $22,489 - $26,163	275 Added 3.25%	8,737 $714,000
Q2 2021 Jul 14, 2021	BUY	$85.24 - $94.15 $50,291 - $55,548	590 Added 7.49%	8,462 $773,000
Q1 2021 Apr 26, 2021	BUY	$83.5 - $98.47 $35,237 - $41,554	422 Added 5.66%	7,872 $673,000
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $56,600 - $68,461	725 Added 10.78%	7,450 $703,000
Q3 2020 Nov 03, 2020	BUY	$82.14 - $91.0 $16,838 - $18,655	205 Added 3.14%	6,725 $585,000
Q1 2020 Apr 22, 2020	BUY	$70.67 - $99.01 $35,900 - $50,297	508 Added 8.45%	6,520 $537,000
Q4 2019 Jan 27, 2020	SELL	$84.35 - $95.37 $5,735 - $6,485	-68 Reduced 1.12%	6,012 $569,000
Q3 2019 Nov 04, 2019	BUY	$85.54 - $94.26 $28,228 - $31,105	330 Added 5.74%	6,080 $529,000
Q2 2019 Aug 01, 2019	BUY	$75.4 - $92.8 $1,508 - $1,856	20 Added 0.35%	5,750 $525,000
Q1 2019 Apr 17, 2019	BUY	$75.32 - $86.15 $5,648 - $6,461	75 Added 1.33%	5,730 $551,000
Q4 2018 Jan 14, 2019	SELL	$73.66 - $82.02 $11,049 - $12,303	-150 Reduced 2.58%	5,655 $485,000
Q3 2018 Oct 23, 2018	BUY	$66.94 - $77.43 $1,004 - $1,161	15 Added 0.26%	5,805 $500,000
Q2 2018 Jul 26, 2018	BUY	$64.91 - $73.36 $4,219 - $4,768	65 Added 1.14%	5,790 $437,000
Q4 2017 Feb 08, 2018	BUY	$72.33 - $77.64 $5,424 - $5,823	75 Added 1.33%	5,725 $481,000
Q3 2017 Nov 03, 2017	BUY	$74.14 - $77.27 $418,891 - $436,575	5,650	5,650 $485,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

News

Stay updated on Rosenbaum Jay D. with notifications on news.

Account